Skip to content

8-KAccepted Dec 3, 8:27 AM ET

Revance Therapeutics, Inc. 8-K

Revance Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

8:27 AM

Dec 3, 2024

Filed

Dec 3, 2024

Documents

13

Size

198.3 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.